Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)
| Country | United States |
|---|---|
| Deadline | Not published |
| Published | 2025-06-27 |
| Source | Grants.gov (US) |
Summary
Funding opportunity FOR-TR-27-002. CFDA: 93.350
The buyer, the value, the full description and the link to the official notice are available with a free account.